Compared with its close competitors within the same industry, KOSPI, the investment return of LG Life Sciences was the most satisfactory among its peer group and its volatility for 1 month was also proper. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -0.8%. Though the volatility was high, the return-on-risk record high value compared with its peer group. Moreover, compared with the KOSPI industry, the return-on-risk is much better than the industrial mean, -1.5, and thus the industrial comparison performance was good.
Close Competitors | Earning rate (%)
Target price KRW 100,000, has 59% disparate to increase compared with stock price.
Per analysts' expectations during the recent month, the average target price of LG Life Sciences is 100,000. The stock price is 62,600 won, so there is 37,400 (59%) disparate in order to be able to increase.
P/E ratio and P/B ratio
Individuals and Foreigners sell, Institutions buy
While institutions have been buying LG Life Sciences during the past 7 trading days, foreigners have been selling during the past 2 trading days. As a shareholding sum by investor group for the past 4 weeks, institutions have bought 277,693 shares with trending trade. However, during the same period, foreigners have sold 136,379 shares with maintenance of a selling position and individuals have sold 141,314 shares as they turn toward a selling stance.
While institutions have been buying LG Life Sciences during the past 7 trading days, foreigners have been selling during the past 2 trading days. As a shareholding sum by investor group for the past 4 weeks, institutions have bought 277,693 shares with trending trade. However, during the same period, foreigners have sold 136,379 shares with maintenance of a selling position and individuals have sold 141,314 shares as they turn toward a selling stance.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.